Tech Center 1600 • Art Units: 1600 1619 1626 1627 1653
This examiner grants 67% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18557775 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF XANTHINE OXIDASE INHIBITOR | Non-Final OA | LG CHEM, LTD. |
| 17265139 | HISTONE DEMETHYLASE 5 INHIBITORS AND USES THEREOF | Non-Final OA | DANA-FARBER CANCER INSTITUTE, INC. |
| 18290328 | NEW SUBSTITUTED PYRIDINES AS FUNGICIDES | Non-Final OA | BASF SE |
| 17920797 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS II | Non-Final OA | BASF SE |
| 17920795 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS III | Non-Final OA | BASF SE |
| 19347608 | TREATMENT METHODS | Final Rejection | Levon Michael Khachigian |
| 17906288 | TREATMENT METHODS | Final Rejection | Levon Michael KHACHIGIAN |
| 19242641 | ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS | Final Rejection | Tarsus Pharmaceuticals, Inc. |
| 18015775 | SMALL MOLECULE INHIBITORS OF TDP-43 ACTIVITY AND USES THEREOF | Non-Final OA | Arizona Board of Regents on Behalf of the University of Arizona |
| 18573372 | CHROMANE IMAGING LIGANDS | Non-Final OA | The General Hospital Corporation |
| 18835167 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | Non-Final OA | Mrja Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy